What Should Gastroenterologists and Patients Know About COVID-19?

TY - JOUR

T1 - What Should Gastroenterologists and Patients Know About COVID-19?

AU - Ungaro, Ryan C.

AU - Sullivan, Timothy

AU - Colombel, Jean Frederic

AU - Patel, Gopi

N1 - Funding Information: Funding Ryan C. Ungaro is supported by a National Institutes of Health K23 Career Development Award (K23KD111995-01A1). Conflicts of interest These authors disclose the following: Ryan C. Ungaro has served as an advisory board member or consultant for Eli Lilly, Janssen, Pfizer, and Takeda; and received research support from AbbVie, Boehringer Ingelheim, and Pfizer. Jean-Frederic Colombel has served as an advisory board member or consultant for AbbVie, Amgen, Boehringer-Ingelheim, Arena Pharmaceuticals, Celgene Corporation, Celltrion, Enterome, Eli Lilly, Ferring Pharmaceuticals, Genentech, Janssen and Janssen, Medimmune, Merck & Co, Nextbiotix, Novartis Pharmaceuticals Corporation, Otsuka Pharmaceutical Development & Commercialization, Pfizer, Protagonist, Second Genome, Gilead, Seres Therapeutics, Shire, Takeda, and Theradiag; has served as a speaker for AbbVie, Ferring, Takeda, and Celgene Corporation; owns stock options for Intestinal Biotech Development, Genefit; and has received research grants from AbbVie, Takeda, Janssen, and Janssen. The remaining authors disclose no conflicts. Funding Information: Funding Ryan C. Ungaro is supported by a National Institutes of Health K23 Career Development Award ( K23KD111995-01A1 ).

PY - 2020/6

Y1 - 2020/6

KW - COVID-19

KW - Coronavirus

UR - http://www.scopus.com/inward/record.url?scp=85083160455&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2020.03.020

DO - 10.1016/j.cgh.2020.03.020

M3 - Article

C2 - 32197957

AN - SCOPUS:85083160455

SN - 1542-3565

VL - 18

SP - 1409

EP - 1411

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 7

ER -